January 10, 2025 12:20 pm (IST)
Government to roll out new drug for treatment of drug-resistant TB
New Delhi, Mar 21 (IBNS) The central government is launching a drug called Bedaquiline on Monday for the treatment of multi-drug resistant tuberculosis (MDR TB) and extensively drug resistant tuberculosis (XDR TB), according to media reports.
Dubbed a 'miracle drug', Bedaquiline (trade name Sirturo) is the first TB drug to be approved by Food and Drug Administration (FDA) in over 40 years.
The project is part of a coordinated programme between the government and Johnson & Johnson and has been rolled out under the Revised National Tuberculosis Control Programme; Janssen, a pharma unit under Johnson & Johnson has manufactured the drug.
The drug will be made available in six public hospitals in Delhi, Mumbai, Chennai, Guwahati and Ahmedabad, according to reports.
In an exclusive interview to Times of India, Sanjiv Navangul, Janssen India MD, said, "We are ready with the roll-out of the drug through the government-run control programme, for which 600 patients will be enrolled across the country, over the next six to nine months, after the required tests. Upon the review of clinical data after two years, the access programme will be expanded nationwide."
As per World Health Organisation (WHO) Global Tuberculosis Report 2015, deaths due to TB were estimated in India to be 2,20,000 in 2014, which is higher than any other country.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Avian flu risk still remains 'low' even after US registers first death due to H5N1 virus, says WHO
Wed, Jan 08 2025
India's HMPV cases surge to 7 after two cases reported from Nagpur
Tue, Jan 07 2025
India's health ministry confirms two HMPV cases in Karnataka
Mon, Jan 06 2025
India detects its first case of HMPV in Bengaluru
Mon, Jan 06 2025
HMPV virus outbreak: India asks WHO to share timely updates on the situation in China
Sun, Jan 05 2025
South Korea: Scientists find way to change cancerous cells back to normal without side effects
Wed, Jan 01 2025
WHO asks China to share data five years after COVID-19
Wed, Jan 01 2025